NIVOLUMAB AND RELATLIMAB-RMBW

NIVOLUMAB AND RELATLIMAB-RMBW was reported 515 times

NIVOLUMAB AND RELATLIMAB-RMBW is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AUTOIMMUNE ENDOCRINE DISORDER 1 0.0476
1 RADIATION RETINOPATHY 1 0.0435
2 METASTATIC OCULAR MELANOMA 1 0.0400
3 ASCARIASIS 1 0.0303
4 IMMUNE-MEDIATED CHOLESTASIS 1 0.0270
5 IMMUNE-MEDIATED GASTROINTESTINAL DISORDER 1 0.0233
6 BRAIN EMPYEMA 1 0.0179
7 VISCERAL VENOUS THROMBOSIS 1 0.0167
8 INTESTINAL MUCOSAL ATROPHY 1 0.0100
9 IMMUNE-MEDIATED MYASTHENIA GRAVIS 3 0.0092
10 MELANOSIS 1 0.0089
11 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 2 0.0088
12 AUTOIMMUNE LUNG DISEASE 1 0.0085
13 TUMOUR HYPERPROGRESSION 2 0.0081
14 IMMUNE-MEDIATED ENDOCRINOPATHY 1 0.0067
15 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 1 0.0055
16 RENAL EMBOLISM 1 0.0054
17 MYXOEDEMA 1 0.0045
18 SARCOID-LIKE REACTION 1 0.0039
19 IMMUNE-MEDIATED MYOCARDITIS 6 0.0037
20 MONKEYPOX 1 0.0036
21 BULBAR PALSY 1 0.0036
22 IMMUNE-MEDIATED MYOSITIS 9 0.0033
23 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
24 VIRAL DIARRHOEA 1 0.0029
25 IMMUNE-MEDIATED CHOLANGITIS 1 0.0028
26 IMMUNE-MEDIATED ARTHRITIS 1 0.0026
27 IMMUNE-MEDIATED PANCREATITIS 1 0.0026
28 MYASTHENIC SYNDROME 2 0.0026
29 SKIN NEOPLASM EXCISION 2 0.0026
30 GIANT CELL ARTERITIS 2 0.0024
31 MELANOMA RECURRENT 1 0.0024
32 AUTOIMMUNE MYOSITIS 1 0.0021
33 PRODUCT STORAGE ISSUE 8 0.0021
34 IMMUNE-MEDIATED THYROIDITIS 1 0.0020
35 IMMUNE-MEDIATED DERMATITIS 2 0.0020
36 IMMUNE-MEDIATED HEPATITIS 4 0.0020
37 EPIGLOTTITIS 1 0.0018
38 RADIATION NECROSIS 1 0.0017
39 METASTATIC MALIGNANT MELANOMA 4 0.0017
40 VITILIGO 4 0.0017
41 MYOCARDITIS 19 0.0017
42 CORTISOL INCREASED 1 0.0016
43 GLIOMA 1 0.0016
44 OESOPHAGEAL ACHALASIA 1 0.0016
45 AUTOIMMUNE COLITIS 1 0.0016
46 MYASTHENIA GRAVIS 12 0.0015
47 LICHEN SCLEROSUS 1 0.0015
48 CYTOKINE STORM 1 0.0015
49 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
50 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
51 TRACHEITIS 1 0.0013
52 OPHTHALMOPLEGIA 2 0.0013
53 REACTION TO PRESERVATIVES 1 0.0012
54 HEPATIC HAEMORRHAGE 1 0.0012
55 PANCREATIC FAILURE 2 0.0011
56 MICROANGIOPATHY 1 0.0011
57 SOLAR LENTIGO 1 0.0011
58 INJECTION SITE SCAB 1 0.0010
59 MUCOSAL DISORDER 1 0.0010
60 HYPOGONADISM 1 0.0010
61 KERATITIS 3 0.0010
62 CAPILLARY LEAK SYNDROME 2 0.0010
63 THYROID HORMONES INCREASED 1 0.0010
64 POLYMYALGIA RHEUMATICA 3 0.0009
65 TROPONIN INCREASED 7 0.0009
66 TUMOUR PSEUDOPROGRESSION 1 0.0009
67 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
68 MYOCARDIAL INJURY 1 0.0009
69 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
70 CORTISOL DECREASED 1 0.0009
71 COLITIS MICROSCOPIC 4 0.0008
72 GUILLAIN-BARRE SYNDROME 4 0.0008
73 METASTASES TO PERITONEUM 2 0.0008
74 PRODUCT PREPARATION ISSUE 5 0.0008
75 ENCEPHALITIS AUTOIMMUNE 1 0.0008
76 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
77 MYASTHENIA GRAVIS CRISIS 1 0.0007
78 MYOSITIS 6 0.0007
79 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
80 SMALL CELL LUNG CANCER 1 0.0007
81 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
82 ACUTE LEUKAEMIA 1 0.0006
83 LINEAR IGA DISEASE 1 0.0006
84 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
85 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
86 TREATMENT DELAYED 1 0.0006
87 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
88 ADRENAL DISORDER 1 0.0005
89 TYPE 1 DIABETES MELLITUS 3 0.0005
90 EXTRAVASATION 2 0.0005
91 METASTASIS 3 0.0004
92 HYPOVOLAEMIC SHOCK 2 0.0004
93 PANNICULITIS 1 0.0004
94 BRAIN ABSCESS 1 0.0004
95 ANGLE CLOSURE GLAUCOMA 1 0.0004
96 CANCER PAIN 1 0.0004
97 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
98 AORTIC ARTERIOSCLEROSIS 1 0.0004
99 LIPOMA 1 0.0004
100 ACTINIC KERATOSIS 1 0.0004
101 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
102 COLITIS 13 0.0003
103 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
104 BRAIN HERNIATION 1 0.0003
105 THYROIDITIS 1 0.0003
106 ADRENAL INSUFFICIENCY 4 0.0003
107 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
108 DERMATITIS ACNEIFORM 2 0.0003
109 BLOOD BLISTER 1 0.0003
110 IRIDOCYCLITIS 1 0.0003
111 MALIGNANT MELANOMA 4 0.0003
112 EYELID PTOSIS 3 0.0003
113 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
114 HYPERTRANSAMINASAEMIA 2 0.0003
115 HYPOTHYROIDISM 9 0.0003
116 HEPATITIS 7 0.0003
117 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
118 RETINOPATHY 1 0.0003
119 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
120 PEMPHIGOID 2 0.0003
121 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
122 AZOTAEMIA 1 0.0003
123 GASTROINTESTINAL PERFORATION 1 0.0002
124 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
125 LUNG NEOPLASM 1 0.0002
126 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
127 TENSION HEADACHE 1 0.0002
128 HEPATOTOXICITY 5 0.0002
129 UVEITIS 3 0.0002
130 PNEUMONITIS 6 0.0002
131 URINE ABNORMALITY 1 0.0002
132 ACUTE HEPATIC FAILURE 3 0.0002
133 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
134 PRODUCT STORAGE ERROR 19 0.0002
135 GASTRITIS EROSIVE 1 0.0002
136 CARDIOMYOPATHY 3 0.0002
137 HEPATIC ENZYME ABNORMAL 1 0.0002
138 PATHOLOGICAL FRACTURE 1 0.0002
139 THYROID DISORDER 3 0.0002
140 BASAL CELL CARCINOMA 3 0.0002
141 POLYARTHRITIS 1 0.0002
142 INTESTINAL ISCHAEMIA 1 0.0002
143 SKIN TOXICITY 1 0.0002
144 METABOLIC DISORDER 1 0.0002
145 STRESS CARDIOMYOPATHY 1 0.0002
146 HYPERCHLORHYDRIA 1 0.0002
147 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
148 HEPATITIS CHOLESTATIC 1 0.0002
149 CHOLANGITIS 1 0.0002
150 HEPATIC CYTOLYSIS 2 0.0002
151 ENTERITIS 1 0.0002
152 COLITIS ISCHAEMIC 1 0.0001
153 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
154 JOINT EFFUSION 1 0.0001
155 ENCEPHALITIS 1 0.0001
156 AUTOIMMUNE HEPATITIS 1 0.0001
157 ADVERSE EVENT 13 0.0001
158 THERMAL BURN 1 0.0001
159 HYPERTHYROIDISM 2 0.0001
160 HYPOPHOSPHATAEMIA 1 0.0001
161 CEREBRAL DISORDER 1 0.0001
162 TRANSAMINASES INCREASED 3 0.0001
163 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
164 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
165 ATRIOVENTRICULAR BLOCK 1 0.0001
166 TRICUSPID VALVE INCOMPETENCE 1 0.0001
167 BLOOD POTASSIUM INCREASED 2 0.0001
168 INFUSION RELATED REACTION 8 0.0001
169 MYOPATHY 1 0.0001
170 DIPLOPIA 3 0.0001
171 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
172 NAIL DISORDER 1 0.0001
173 NEUROTOXICITY 2 0.0001
174 IMMUNOSUPPRESSION 1 0.0001
175 PURPURA 1 0.0001
176 CARDIOTOXICITY 1 0.0001
177 GASTROINTESTINAL INFECTION 1 0.0001
178 IRON DEFICIENCY ANAEMIA 1 0.0001
179 MENTAL STATUS CHANGES 3 0.0001
180 PRODUCT DISTRIBUTION ISSUE 1 0.0001
181 BLOOD SODIUM DECREASED 2 0.0001
182 SPUTUM DISCOLOURED 1 0.0001
183 RECALLED PRODUCT ADMINISTERED 1 0.0001
184 THROMBOTIC MICROANGIOPATHY 1 0.0001
185 AUTOIMMUNE DISORDER 1 0.0001
186 VITAMIN D DEFICIENCY 1 0.0001
187 VITREOUS FLOATERS 1 0.0001
188 HOSPICE CARE 1 0.0001
189 PRESCRIBED UNDERDOSE 2 0.0001
190 SLUGGISHNESS 1 0.0001
191 TEMPERATURE INTOLERANCE 1 0.0001
192 PERITONITIS 2 0.0001
193 PETECHIAE 1 0.0001
194 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
195 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
196 PRODUCT PRESCRIBING ISSUE 2 0.0001
197 INJECTION SITE NODULE 1 0.0001
198 STEVENS-JOHNSON SYNDROME 2 0.0001
199 MALNUTRITION 1 0.0001
200 INTESTINAL PERFORATION 1 0.0001
201 DEATH 76 0.0001
202 METASTASES TO LUNG 1 0.0001
203 BLOOD IRON DECREASED 1 0.0001
204 DIABETIC KETOACIDOSIS 2 0.0001
205 ENCEPHALOPATHY 2 0.0001
206 GENERALISED OEDEMA 1 0.0001
207 BRAIN OEDEMA 1 0.0001
208 BEDRIDDEN 1 0.0001
209 ADVERSE REACTION 1 0.0001
210 GINGIVAL BLEEDING 1 0.0001
211 SKIN LESION 2 0.0001
212 PERIPHERAL COLDNESS 1 0.0001
213 COORDINATION ABNORMAL 1 0.0001
214 SUBDURAL HAEMATOMA 1 0.0001
215 OFF LABEL USE 60 0.0001
216 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
217 ASCITES 2 0.0001
218 RESPIRATORY DISORDER 2 0.0001
219 APHASIA 2 0.0001
220 INSURANCE ISSUE 1 0.0001
221 LYMPHOMA 1 0.0001
222 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
223 NIGHT SWEATS 2 0.0001
224 MUSCULAR WEAKNESS 7 0.0001
225 METASTASES TO BONE 1 0.0001
226 PHOTOSENSITIVITY REACTION 1 0.0001
227 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
228 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
229 ACUTE KIDNEY INJURY 9 0.0001
230 SCAR 1 0.0001
231 MUSCULOSKELETAL DISCOMFORT 1 0.0001
232 METASTASES TO LIVER 1 0.0001
233 PANCREATITIS 3 0.0001
234 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
235 ISCHAEMIC STROKE 1 0.0001
236 GALLBLADDER DISORDER 1 0.0001
237 THERAPY INTERRUPTED 4 0.0001
238 THIRST 1 0.0001
239 PULMONARY FIBROSIS 1 0.0001
240 CHOLESTASIS 1 0.0001
241 POST PROCEDURAL COMPLICATION 1 0.0001
242 EAR PAIN 1 0.0001
243 HAEMORRHOIDS 1 0.0001
244 PRODUCT DOSE OMISSION ISSUE 15 0.0001
245 DISABILITY 1 0.0001
246 CYTOKINE RELEASE SYNDROME 1 0.0000
247 PLEURAL EFFUSION 3 0.0000
248 BLINDNESS 2 0.0000
249 PRODUCT PREPARATION ERROR 1 0.0000
250 PULMONARY HYPERTENSION 1 0.0000
251 RHABDOMYOLYSIS 2 0.0000
252 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
253 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
254 RASH MACULO-PAPULAR 1 0.0000
255 COLITIS ULCERATIVE 2 0.0000
256 ORAL PAIN 1 0.0000
257 PANCREATITIS ACUTE 1 0.0000
258 PRODUCT AVAILABILITY ISSUE 1 0.0000
259 PERICARDIAL EFFUSION 1 0.0000
260 RENAL DISORDER 2 0.0000
261 PRODUCT PRESCRIBING ERROR 1 0.0000
262 BLOOD PRESSURE FLUCTUATION 1 0.0000
263 PRESYNCOPE 1 0.0000
264 CARDIOVASCULAR DISORDER 1 0.0000
265 HOSPITALISATION 6 0.0000
266 ILLNESS 4 0.0000
267 ANAPHYLACTIC SHOCK 1 0.0000
268 HAEMATOMA 1 0.0000
269 MUSCULOSKELETAL PAIN 2 0.0000
270 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
271 JAUNDICE 1 0.0000
272 RASH PRURITIC 2 0.0000
273 TREATMENT NONCOMPLIANCE 2 0.0000
274 DIVERTICULITIS 1 0.0000
275 DEMENTIA 1 0.0000
276 THROMBOCYTOPENIA 4 0.0000
277 BLISTER 2 0.0000
278 HYPONATRAEMIA 2 0.0000
279 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
280 MYALGIA 6 0.0000
281 INTENTIONAL DOSE OMISSION 1 0.0000
282 DECREASED APPETITE 8 0.0000
283 DYSPHONIA 2 0.0000
284 BLOOD POTASSIUM DECREASED 1 0.0000
285 LACRIMATION INCREASED 1 0.0000
286 EPILEPSY 1 0.0000
287 WEIGHT DECREASED 9 0.0000
288 NERVOUS SYSTEM DISORDER 1 0.0000
289 SWOLLEN TONGUE 1 0.0000
290 HIP FRACTURE 1 0.0000
291 OSTEONECROSIS 1 0.0000
292 STAPHYLOCOCCAL INFECTION 1 0.0000
293 VIRAL INFECTION 1 0.0000
294 LIP SWELLING 1 0.0000
295 RASH 13 0.0000
296 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
297 HEPATIC ENZYME INCREASED 2 0.0000
298 NEOPLASM PROGRESSION 1 0.0000
299 RASH MACULAR 1 0.0000
300 HEART RATE DECREASED 1 0.0000
301 CEREBRAL HAEMORRHAGE 1 0.0000
302 C-REACTIVE PROTEIN INCREASED 1 0.0000
303 HYPERGLYCAEMIA 1 0.0000
304 INFLUENZA 3 0.0000
305 SEPSIS 3 0.0000
306 DYSPNOEA EXERTIONAL 1 0.0000
307 SEIZURE 3 0.0000
308 PERIPHERAL SWELLING 4 0.0000
309 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
310 BACK PAIN 6 0.0000
311 ABDOMINAL PAIN 6 0.0000
312 FATIGUE 19 0.0000
313 LUNG NEOPLASM MALIGNANT 1 0.0000
314 OSTEOPOROSIS 1 0.0000
315 HYPERTENSION 5 0.0000
316 URINARY TRACT INFECTION 4 0.0000
317 HYPOACUSIS 1 0.0000
318 DEVICE DISLOCATION 1 0.0000
319 LIVER DISORDER 1 0.0000
320 GASTROINTESTINAL DISORDER 2 0.0000
321 THERAPY NON-RESPONDER 1 0.0000
322 SKIN IRRITATION 1 0.0000
323 NEPHROLITHIASIS 1 0.0000
324 COGNITIVE DISORDER 1 0.0000
325 SWELLING 2 0.0000
326 COMA 1 0.0000
327 ANAEMIA 4 0.0000
328 GAIT DISTURBANCE 4 0.0000
329 INTERSTITIAL LUNG DISEASE 1 0.0000
330 DRY EYE 1 0.0000
331 FLUSHING 2 0.0000
332 FLUID RETENTION 1 0.0000
333 SINUSITIS 2 0.0000
334 THERAPY CESSATION 1 0.0000
335 SPEECH DISORDER 1 0.0000
336 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
337 DIARRHOEA 12 0.0000
338 OEDEMA 1 0.0000
339 ANAPHYLACTIC REACTION 1 0.0000
340 ARTHROPATHY 1 0.0000
341 NECK PAIN 1 0.0000
342 PANCYTOPENIA 1 0.0000
343 WEIGHT INCREASED 4 0.0000
344 OXYGEN SATURATION DECREASED 1 0.0000
345 EYE PAIN 1 0.0000
346 CEREBROVASCULAR ACCIDENT 3 0.0000
347 LETHARGY 1 0.0000
348 WHEEZING 1 0.0000
349 ARTHRALGIA 7 0.0000
350 CATARACT 1 0.0000
351 STOMATITIS 1 0.0000
352 FEELING HOT 1 0.0000
353 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
354 CHEST PAIN 3 0.0000
355 PRURITUS 6 0.0000
356 PSORIASIS 2 0.0000
357 BLOOD PRESSURE DECREASED 1 0.0000
358 DEHYDRATION 2 0.0000
359 VISION BLURRED 2 0.0000
360 MEMORY IMPAIRMENT 2 0.0000
361 HEADACHE 9 0.0000
362 COUGH 4 0.0000
363 SLEEP DISORDER 1 0.0000
364 DYSPNOEA 8 0.0000
365 MOBILITY DECREASED 1 0.0000
366 INFECTION 2 0.0000
367 EPISTAXIS 1 0.0000
368 HYPOAESTHESIA 2 0.0000
369 ASTHENIA 5 0.0000
370 INCORRECT DOSE ADMINISTERED 3 0.0000
371 VOMITING 6 0.0000
372 ARTHRITIS 1 0.0000
373 CARDIAC FAILURE 1 0.0000
374 THROMBOSIS 1 0.0000
375 CONFUSIONAL STATE 2 0.0000
376 DRY MOUTH 1 0.0000
377 INFLUENZA LIKE ILLNESS 1 0.0000
378 CARDIAC ARREST 1 0.0000
379 TREATMENT FAILURE 1 0.0000
380 TREMOR 2 0.0000
381 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
382 URTICARIA 2 0.0000
383 INTENTIONAL PRODUCT MISUSE 1 0.0000
384 MUSCULOSKELETAL STIFFNESS 1 0.0000
385 COVID-19 2 0.0000
386 PAIN 7 0.0000
387 TACHYCARDIA 1 0.0000
388 HYPERSENSITIVITY 2 0.0000
389 PULMONARY EMBOLISM 1 0.0000
390 CONTUSION 1 0.0000
391 DYSPEPSIA 1 0.0000
392 CHEST DISCOMFORT 1 0.0000
393 ABDOMINAL DISTENSION 1 0.0000
394 CONSTIPATION 2 0.0000
395 MALAISE 4 0.0000
396 FALL 3 0.0000
397 NAUSEA 7 0.0000
398 RHEUMATOID ARTHRITIS 1 0.0000
399 PALPITATIONS 1 0.0000
400 CHILLS 1 0.0000
401 DISEASE PROGRESSION 1 0.0000
402 FEELING ABNORMAL 2 0.0000
403 OEDEMA PERIPHERAL 1 0.0000
404 VISUAL IMPAIRMENT 1 0.0000
405 INJECTION SITE ERYTHEMA 1 0.0000
406 LOSS OF CONSCIOUSNESS 1 0.0000
407 RENAL FAILURE 1 0.0000
408 NEUTROPENIA 1 0.0000
409 PAIN IN EXTREMITY 2 0.0000
410 PARAESTHESIA 1 0.0000
411 DRUG INTERACTION 1 0.0000
412 PNEUMONIA 2 0.0000
413 PYREXIA 2 0.0000
414 MYOCARDIAL INFARCTION 1 0.0000
415 NO ADVERSE EVENT 1 0.0000
416 BLOOD GLUCOSE INCREASED 1 0.0000
417 SOMNOLENCE 1 0.0000
418 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
419 ERYTHEMA 1 0.0000
420 ABDOMINAL PAIN UPPER 1 0.0000
421 DRUG INEFFECTIVE 5 0.0000
422 INSOMNIA 1 0.0000
423 CONDITION AGGRAVATED 1 0.0000